AAPL 221.875 -3.5242% MSFT 427.22 -0.4219% NVDA 139.85 1.554% GOOGL 199.3225 1.6952% GOOG 201.35 1.9236% AMZN 228.7043 1.2235% META 617.385 0.7531% AVGO 239.5299 0.8802% TSLA 413.825 -2.9719% TSM 213.7392 1.0587% LLY 735.7301 1.3793% V 322.15 0.7916% JPM 261.25 0.8065% UNH 520.02 2.0127% NVO 80.28 2.0206% WMT 93.245 1.4194% LVMUY 145.13 2.1467% XOM 111.61 -0.6321% LVMHF 725.1 1.976% MA 529.315 0.8796%
AAPL 221.875 -3.5242% MSFT 427.22 -0.4219% NVDA 139.85 1.554% GOOGL 199.3225 1.6952% GOOG 201.35 1.9236% AMZN 228.7043 1.2235% META 617.385 0.7531% AVGO 239.5299 0.8802% TSLA 413.825 -2.9719% TSM 213.7392 1.0587% LLY 735.7301 1.3793% V 322.15 0.7916% JPM 261.25 0.8065% UNH 520.02 2.0127% NVO 80.28 2.0206% WMT 93.245 1.4194% LVMUY 145.13 2.1467% XOM 111.61 -0.6321% LVMHF 725.1 1.976% MA 529.315 0.8796%

CB Scientific Inc

Healthcare US CBSC

0.12USD
-(-%)

Last update at 2025-01-17T20:50:00Z

Day Range

0.100.12
LowHigh

52 Week Range

0.030.12
LowHigh

Fundamentals

  • Previous Close 0.12
  • Market Cap6.50M
  • Volume16600
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.71635M
  • Revenue TTM0.05M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.02M
  • Diluted EPS TTM-

Financials

Income Statement

2017-03-312018-03-312021-03-312022-03-312023-03-31-6M-5.5M-5M-4.5M-4M-3.5M-3M-2.5M-2M-1.5M-1M-0.5M0M
Total Revenue
Net Income

Balancesheet

2018-03-312021-03-312022-03-312023-03-312024-03-310M0.1M0.2M0.3M0.4M0.5M0.6M0.7M0.8M0.9M1M1.1M1.2M
Total Assets
Total Liabilities

Change in Cash

2017-03-312018-03-312021-03-312022-03-312023-03-31-0.25M-0.2M-0.15M-0.1M-0.05M0M0.05M0.1M0.15M0.2M0.25M0.3M0.35M0.4M

Total Operating Cash

2017-03-312018-03-312021-03-312022-03-312023-03-31-1.2M-1.1M-1M-0.9M-0.8M-0.7M-0.6M-0.5M-0.4M-0.3M-0.2M-0.1M0M

Dividends Paid

2017-03-312018-03-312021-03-312022-03-312023-03-310M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2018-03-31 2017-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2018-03-31 2017-03-31
Income before tax -2.10658M -6.34228M -4.32768M -1.13139M -0.38602M
Minority interest - - - 0.00000M 0.00000M
Net income -2.10658M -6.34228M -4.32768M -1.13139M -0.38602M
Selling general administrative 2.14M 1.80M 2.96M 0.49M 0.37M
Selling and marketing expenses - - - - -
Gross profit 0.04M -0.07366M 0.02M 0.02M 0.02M
Reconciled depreciation 0.00000M 0.00061M 0.00675M - -
Ebit - - - -1.13139M -0.36977M
Ebitda -2.10137M -4.79785M -3.97663M - -
Depreciation and amortization - - - - -
Non operating income net other - - - 0.00000M 0.00000M
Operating income -2.10191M -1.87082M -2.94261M -1.13139M -0.36977M
Other operating expenses - - - 0.66M 0.02M
Interest expense 0.00521M 1.54M 0.34M 0.00000M 0.00000M
Tax provision - - - - -
Interest income 0.00054M - - - -
Net interest income -0.00466M -1.54381M -0.34430M - -
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense - - - 0.00000M 0.00000M
Total revenue 0.08M 0.08M 0.03M 0.04M 0.03M
Total operating expenses 2.18M 1.95M 2.98M 1.17M 0.40M
Cost of revenue 0.04M 0.15M 0.00981M 0.01M 0.02M
Total other income expense net - -2.92764M -1.04077M 0.00000M -0.01625M
Discontinued operations - - - 0.00000M 0.00000M
Net income from continuing ops -2.10658M -6.34228M -4.32768M -1.13139M -0.38602M
Net income applicable to common shares - - - -1.13139M -0.38602M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2018-03-31
Total assets 0.30M 0.30M 0.65M 0.31M 0.06M
Intangible assets - - - - 0.02M
Earning assets - - - - -
Other current assets 0.02M - - - 0.00000M
Total liab 0.94M 0.68M 0.16M 0.50M 1.27M
Total stockholder equity -0.64281M -0.37686M 0.49M -0.18988M -1.22372M
Deferred long term liab - - - - 0.00000M
Other current liab 0.61M - - - 0.51M
Common stock 0.15M - - - 0.06M
Capital stock 0.16M 0.13M 0.11M 0.08M -
Retained earnings -16.32994M -14.69970M -12.63696M -6.29468M -1.71808M
Other liab - - - - 0.00000M
Good will - - - - 0.00000M
Other assets - - - - 0.00000M
Cash 0.13M 0.14M 0.43M 0.02M 0.00467M
Cash and equivalents - - - - -
Total current liabilities 0.83M 0.68M 0.16M 0.50M 1.27M
Current deferred revenue 0.17M - - - -
Net debt -0.10510M - - 0.37M -
Short term debt 0.02M - - - 0.00000M
Short long term debt 0.02M 0.10M 0.04M 0.38M 0.00000M
Short long term debt total 0.02M - - - -
Other stockholder equity 15.53M - - - 0.00000M
Property plant equipment - - - - 0.00540M
Total current assets 0.18M 0.18M 0.65M 0.31M 0.03M
Long term investments - - - - 0.00000M
Net tangible assets - - - - -1.24854M
Short term investments - - - - 0.00000M
Net receivables 0.00468M 0.00385M 0.05M 0.01M 0.01M
Long term debt - - - 0.00510M 0.00000M
Inventory 0.03M 0.02M 0.00927M 0.15M 0.01M
Accounts payable 0.03M 0.02M 0.00977M 0.00921M 0.15M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income 0.00200M - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 0.12M - - - 0.00000M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 0.12M 0.12M 0.00000M 0.00061M 0.00000M
Capital lease obligations - - - - 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2018-03-31 2017-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2018-03-31 2017-03-31
Investments 0.04M -0.04000M -0.12500M 0.00000M 0.00000M
Change to liabilities - - - 0.02M 0.13M
Total cashflows from investing activities - - - -0.00635M -0.00053M
Net borrowings - - - 0.09M 0.08M
Total cash from financing activities 0.86M 1.23M 0.79M 0.77M 0.08M
Change to operating activities - - - 0.32M 0.18M
Net income -2.10658M -6.34228M -4.32768M -1.13139M -0.38602M
Change in cash -0.29052M 0.41M 0.00375M -0.00783M 0.01M
Begin period cash flow 0.43M 0.02M 0.01M - -
End period cash flow 0.14M 0.43M 0.02M 0.01M -
Total cash from operating activities -1.18700M -0.78603M -0.66259M -0.76873M -0.06250M
Issuance of capital stock 0.25M - - - -
Depreciation 0.00000M 0.00061M 0.00675M 0.00273M 0.00048M
Other cashflows from investing activities - - - 0.00000M 0.00000M
Dividends paid - - - 0.00000M 0.00000M
Change to inventory -0.01412M 0.02M 0.00000M 0.02M -0.00260M
Change to account receivables - - - -0.00114M 0.00790M
Sale purchase of stock - - - 0.00000M 0.00000M
Other cashflows from financing activities - - - 0.00000M 0.00000M
Change to netincome - - - 0.00000M 0.00000M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00342M 0.00053M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital 0.48M 0.18M 0.21M - -
Stock based compensation 0.10M - - - -
Other non cash items 0.34M 2.30M 3.44M - -
Free cash flow -1.18700M -0.78603M -0.66259M - -

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBSC
CB Scientific Inc
- -% 0.12 - - 129.10 261.27 87.51 -10.2022
ISRG
Intuitive Surgical Inc
6.52 1.10% 599.16 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA
2.68 2.13% 128.78 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme
- -% 249.58 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company
2.44 1.03% 239.82 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

Profile

CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide improved compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. The company is based in Las Vegas, Nevada.

CB Scientific Inc

10845 Griffith Peak Drive, Las Vegas, NV, United States, 89135

Key Executives

Name Title Year Born
Mr. Charles K. Martin III Pres, CEO & Director 1956
Ms. Brooke Martellaro Chief Financial Officer NA
Mr. James Ott CTO & Director NA
Mr. Charles K. Martin III President, CEO & Director 1956
Mr. William Griffin Thomas CPA CFO & Treasurer 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.